Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights

DALLAS--(BUSINESS WIRE)--Nov 8, 2023--

Related Keywords

Bengaluru ,Karnataka ,India ,South Korea ,Canada ,Japan ,Vancouver ,British Columbia ,Taiwan ,Texas ,United States ,Boston ,Massachusetts ,Kishor Bhatia ,John Laterra ,Johns Hopkins Medicine Kennedy Krieger Institute ,Lantern Pharma Inc ,Society For Neuro ,Fox Chase Cancer Center ,Securities Exchange ,Exchange Commission On ,Ai Machine Learning To Accelerate The Development ,Nasdaq ,Starlight Therapeutics Inc ,Panna Sharma ,Powered Pipeline ,Johns Hopkins ,Platform Growth ,Starlight Therapeutics ,Operational Highlights ,Annual Meeting ,Education Day ,Johns Hopkins Medicine ,Kennedy Krieger Institute ,Tech Summit ,Biotech Future Forward ,Delivery Summit ,Webinar Details ,Lantern Pharma ,Securities Act ,Securities Exchange Act ,Risk Factors ,Annual Report ,Exchange Commission ,Pharma Disclosure Channels ,Disseminate Information ,Business Wire ,Region ,